The risk for cardiovascular disease (CVD) increases with advancing age; however, the age at which CVD risk increases significantly is delayed by more than a decade in women compared to men. This cardioprotection, which women experience until menopause, is presumably due to the presence of ovarian hormones, in particular estrogen. The purpose of this study was to determine how age and ovarian hormones affect flow-induced vasodilation in the coronary resistance vasculature. Coronary arterioles were isolated from young (6 mos), middle-aged (14 mos), and old (24 mos) intact, ovariectomized (OVX) and ovariectomized + estrogen replaced (OVE) female Fischer-344 rats to assess flow-induced vasodilation. Advancing age impaired flowinduced dilation of coronary arterioles (Young: 50 ± 4 vs. Old: 34 ± 6; % relaxation).
INTRODUCTION
The risk for cardiovascular disease (CVD) and heart failure increase with advancing age; however, sexual dimorphism exists in the chronological development of these risks (22, 47) . Although the chronological rate of aging is independent of gender, mechanisms that regulate the cardiovascular system across the lifespan may differ dramatically between men and women. The risk for CVD in men begins to increase at approximately the same age that flow-mediated vasodilation begins to decline (5) .
Women also exhibit this age-related impairment of flow-mediated vasodilation; however, significant reduction of flow-mediated dilation becomes apparent at the age of menopause, more than a decade later than in men (5) . The cardioprotection that women experience until menopause, is presumably due to the presence of ovarian estrogen and results in a gender-related delay of the expression of CVD (49) .
Chronic estrogen treatment has been shown to enhance endothelial function in a number of vascular beds (27, 31, 39) in part through a pathway involving activation of AKT/PKB and subsequent phosphorylation of endothelial nitric oxide synthase (eNOS) (3, 10, 15, 43, 44) . Endothelium-dependent vasodilation to acetylcholine in the peripheral vasculature is preserved or potentiated with chronic estrogen treatment in male, ovariectomized (OVX) and sham-operated rats (26, 27, 34, 52) . A number of studies have shown that chronic estrogen treatment enhances endothelium-dependent vasodilation in large peripheral arteries of postmenopausal women (7, 24, 38) .
In contrast to these reports of the cardioprotective effects of estrogen, the Women's Health Initiative (WHI) (37) and Heart and Estrogen/Progestin Replacement Study (HERS) (19) found an increased risk for coronary heart disease and stroke in postmenopausal women taking hormone-replacement therapy (HRT) compared to nonusers of HRT. This negative effect of HRT in postmenopausal women in the randomized clinical trials prompted investigations into the disparate results of animal studies which have found a beneficial effect of chronic estrogen treatment (2, 26, 52) . Even in humans, postmenopausal women have shown improved endothelium-dependent function in both small and large coronary arteries after short-term administration of estrogen (11, 13) , raising questions as to why long-term HRT increases the risk for coronary heart disease in women after menopause. Discrepancies in the timing of hormone-replacement initiation, type and dose of estrogen/progesterone, and the age and health of women in clinical studies (32) warrants an optimized, pertinent animal model that more closely resembles reproductive aging in women. The present study utilizes a unique model, which allows identification of age-related changes in the coronary resistance vasculature while incorporating interventions such as the loss of ovarian hormones and/or estrogen replacement at appropriate timepoints in the reproductive lifespan.
The purpose of this study was to determine how advancing age, ovariectomy, and estrogen-replacement affect endothelium-dependent, flow-induced vasodilation in the coronary resistance vasculature. We hypothesized that increasing age and lack of ovarian hormones would decrease flow-induced dilation in coronary arterioles. This study specifically investigated whether alterations in nitric oxide (NO) signaling underlie ageand estrogen-mediated changes in endothelium-dependent vasodilation.
METHODS
Animals. Young (4 mos), middle-aged (12 mos) and old (22 mos) female Fischer-344 rats were obtained from Harlan (Indianapolis, IN). At the time of arrival, rats were maintained with ovaries intact (Intact), ovariectomized (OVX), or ovariectomized + estrogen-replaced (OVE) and housed for 6 to 8 weeks post-operatively. Ages at the time of sacrifice were 6, 14, and 24 months for young, middle-aged and old rats, respectively. All procedures were approved by the Institutional Animal Care and Use Committee at West Virginia University and the University of Florida and conformed to the National Institutes of Health Guide for the Care and Use of Laboratory Animals (National Research Council, Washington D.C., Revised 1996). Rats were housed individually at 23º C and were maintained on a 12:12-h light-dark cycle. All rats were fed a phytoestrogen-free rat chow and water ad libitum. Prior to sacrifice, at least two complete estrous cycles were monitored in all female rats by daily vaginal smears. At the time of sacrifice, 3 ml of blood were collected into chilled tubes containing dipotassium EDTA. Blood samples were centrifuged at 10,000 rpm at 4°C for 5 min, and the plasma was collected stored at -80ºC for later analysis. The ovaries (in intact females), uterus, and cervix were dissected and trimmed of connective tissue and fat to obtain uterine weight (UW). Plasma estradiol was determined with ELISA immunoassay (Estradiol EIA kit, Oxford Biomedical; Oxford, MI).
Surgical Procedures. OVX surgeries were performed as described previously (35). Briefly, rats were anesthetized with isoflurane (3%/oxygen balance). Bilateral dorsolateral incisions were made through the top layer of skin and the underlying muscles were bluntly dissected in order to locate the ovary and fallopian tube. The fallopian tube was ligated with absorbable suture, and the ovary was removed. The surrounding fat pad was returned to the abdominal cavity, and the musculature and outer layer of skin were was sutured. Non-absorbable suture used to suture the skin was removed 7-10 d following surgery. OVE was performed simultaneous to the OVX procedure. Two 0.05 mg 17beta-estradiol 60-day slow release pellets (Innovative Research) were implanted subcutaneously near the scapulae.
Microvessel Preparation. Six to eight weeks after surgery, rats were anesthetized (Isoflurane 5%/O 2 balance) and euthanized by removal of the heart. Coronary arterioles from the left anterior descending artery (LAD) distribution were isolated and cannulated as described previously (42) . Arterioles were cannulated on pipettes matched (within 1%) for size and resistance and pressurized at 60 cm H 2 O (~45 mm Hg). Arterioles unable to hold pressure due to leaks were discarded. Those without leaks were warmed to 37° C and allowed to develop spontaneous tone.
Evaluation of vasodilator responses to intraluminal flow.
Responses to flow were used to determine endothelial responsiveness to intraluminal shear stress. Once steady tone was achieved, arterioles were exposed to graded increases in intraluminal flow at constant pressure by adjusting the height of the fluid reservoirs in equal but opposite directions, thereby creating a pressure difference across the arterioles without altering pressure within the arterioles (21). Diameter measurements were determined in response to pressure differences of 2, 4, 10, 20, 40, and 60 cm H 2 O, corresponding to physiologically significant flow rates from 5 to 50 nl/sec (28) .
Responses to Dea-NONOate. Concentration-response relations to cumulative addition of the nitric oxide donor Dea-NONOate (3x10 -9 M -1x10 -4 M) were determined in order to determine responsiveness of the vascular smooth muscle to NO. both inhibitors (L-NAME +INDO) was applied to vessels during exposure to flow.
Inhibitor incubation was performed for a minimum of 30 min prior to beginning experiments.
mRNA levels. Arterioles were snap frozen and stored at -80°C. Arterioles were later pulverized in lysate buffer and total RNA was extracted using an aqueous and ethanol filter isolation method (RNAqueous Isolation Kit, Ambion). Real-time PCR was performed with TaqMan® probes (Applied Biosystems) specific for rat AKT-1 (Applied Biosystems). Custom TaqMan(R) probes were designed from the published sequences for rat eNOS (eNOS primers at exon 8-9 junction: forward, GTG ACC CTC ACC GAT ACA ACA TAC; reverse, TGT CCG GGT GTC TAG ATC CAT). The fluorescent signal from the probe (FAM-labeled reporter dye; NFQ labeled-quencher dye) was measured by the ABI prism 7900HT Fast Real-Time PCR system as described previously (45) . Levels of the target sequence and levels of co-amplified 18S ribosomal RNA were quantified relative to the cycle number (cycle threshold, C T ), at which the target and 18S
reach a fixed threshold as described previously (45 Flow-diameter and concentration-diameter curves were evaluated by three way ANOVA with repeated measures on one factor in order to detect differences within (flow rate or concentration) and between (experimental groups) factors. Pairwise comparisons were made by post-hoc analysis (Bonferroni's) when a significant main effect was found. Two-way ANOVA was used to determine group differences in body weight, heart weight, heart weight/body weight ratio, uterine weight, uterine weight/body weight ratio, spontaneous tone, and maximal diameter. One-way ANOVA was used to compare numeric plasma estradiol concentrations between treatments (Intact, OVX, OVE) within each age group. In some samples, estradiol concentrations were low enough to fall below the limit of detection of the assay (approximately 10 pg/ml); therefore, uterine weight/body weight ratios and estradiol concentrations were transformed to rank order, and a nonparametric correlation coefficient using Spearman's rho test was calculated to determine if there was a significant predictive relationship between uterine weight/body weight ratio and plasma estradiol concentration. In all statistical analyses, n indicates the number of animals in each group. Significance was defined as P ≤ 0.05.
RESULTS

Animal Characteristics
Middle-age and old intact rats exhibited a greater body weight and heart weight than young intact rats ( Table 1 ). The ratio of heart weight (HW) to body weight (BW) was lower in middle-age and old intact rats compared to young intact rats (Table 1) .
OVX induced a significant increase in BW in young females and decreased HW/BW ratio in young and middle-age females (Table 1) . Estrogen-replacement caused a decrease in BW and an increase in HW/BW compared to OVX in all age groups. In middle-age and old females, BW decreased and HW/BW increased in OVE compared to age-matched intact (Table 1) . Serum estradiol measurements were positively correlated with uterine weight (UW)/BW ratios (Slope = 0.450, P=0.001, Fig 1A) . Vaginal smears performed for 8 consecutive days prior to sacrifice revealed that the majority of old intact females are in constant diestrous at the time of sacrifice as compared to regularly cycling young intact females ( Fig 1B) . Subsequent analysis of the estrous cycle at time of sacrifice revealed no significant effect of cycle on vascular reactivity (Fig 1C) , which is consistent with findings reported in rat aorta (46) . Uterine weight was reduced by OVX in rats of all age groups, whereas uterine weight was increased in OVE rats as compared to OVX rats of all age groups (Fig 1D) . Young intact females had greater plasma estradiol compared to middle-aged and old intact females (Fig 1D) . OVX decreased plasma estradiol in young intact, and estrogen-replacement restored estradiol to levels to those of young intact females (Fig 1D) . OVX did not alter plasma estradiol in middleaged and old females compared to the age-matched intact rats (Fig 1D) . Estrogenreplacement increased estradiol in old females compared to old intact rats (Fig 1D) .
Vessel Characteristics
Maximal diameter was similar among arterioles from all female groups except young OVE rats, in which maximal diameter was reduced ( Table 2 ). Spontaneous tone was not altered by age or changes in estrogen status. Treatment with L-NAME increased tone to a similar degree in arterioles from all groups ( Table 2 ). Indomethacin did not significantly alter tone in arterioles from any group compared to spontaneous tone prior to treatment (Table 2) . L-NAME + indomethacin increased spontaneous tone to a similar degree in coronary arterioles from all groups except for young intact and middle-aged OVX rats (Table 2) .
Vasodilator responses to flow
Flow-induced dilation in coronary arterioles from old females was impaired compared to those from young females (Fig 2) . Flow-induced dilation in arterioles from middle-aged females was intermediate between young and old females, but not significantly different from the dilation in arterioles from either young or old rats.
OVX effect on flow-induced dilation
Flow-induced dilation of coronary arterioles from young females declined following OVX (Fig 3A) , whereas dilation of coronary arterioles to flow in middle-age OVX females was slightly, but not significantly, decreased compared to intact females of the same age (Fig 3B) . Flow-induced dilation of coronary arterioles was unchanged in old females after OVX (Fig 3C) OVE effect on flow-induced dilation OVE significantly improved dilation of coronary arterioles to flow in all age groups compared to OVX (Fig 3) . In old females, estrogen-replacement augmented flowinduced dilation to a level significantly greater than that of arterioles from either intact or OVX rats (Old OVE: 54.5% ± 6.5, Old OVX: 23.2% ± 8.2, Old Intact: 30.2% ± 5.8) ( Fig   3C) .
NOS inhibition
To determine whether NO contributed to flow-induced dilation in coronary arterioles, dilation to flow was assessed in the presence of a nonspecific inhibitor of NOS (L-NAME). In intact females, only arterioles from young rats exhibited a decrease in flow-induced dilation after L-NAME treatment (Fig 4A) , indicating a loss of NO contribution to flow with advancing age. Flow-induced dilation in OVX females of all ages was impervious to prior incubation with L-NAME (Fig 5A) . Conversely, blockade with L-NAME abolished dilation to flow in all OVE females, indicating a reliance on NO-dependent vasodilation after estrogen replacement, regardless of age (Fig 5B) .
COX inhibition
In arterioles from young and middle-aged rats, indomethacin treatment had no effect on flow-induced dilation, regardless of estrogen status (data not shown). In arterioles from old intact females, indomethacin treatment increased maximal flowinduced vasodilation (Fig 6) , suggesting that a COX-dependent constrictor pathway limits flow-induced dilation at an advanced age (Fig 6) . In contrast, indomethacin reduced flow-induced dilation in arterioles from old OVE females (Fig 6) , suggesting that estrogen replacement increases the contribution of COX-mediated signaling to flowinduced dilation in arterioles from old rats.
Combined NOS and COX inhibition
In all groups, combined NOS and COX inhibition on flow-induced dilation in coronary arterioles was similar to NOS inhibition alone (data not shown).
Vasodilator responses to DEA-NONOate
To determine whether the age-related impairment of vasodilation in coronary arterioles was due to a decrease in smooth muscle responsiveness to NO, vasodilation to DEA-NONOate was measured. DEA-NONOate elicited similar dilation in coronary arterioles from young, middle-aged, and old intact females (Fig 7A) . In young and old rats, netiher OVX or OVE altered dilation of coronary arterioles to DEA-NONOate ats (Fig 7, B and D) . Coronary arterioles from middle-aged OVE rats exhibited increased sensitivity to DEA-NONOate as compared to those from middle-age OVX rats (IC 50 :
Middle-age OVX = 2.31x10 -6 M, Middle-age OVE = 7.01x10 -7 M; Fig 7C) .
AKT and eNOS mRNA levels
In coronary arterioles from intact females, AKT mRNA expression declined with age ( Fig 8A) . OVX decreased (vs. intact), whereas OVE increased (vs. OVX) AKT mRNA in coronary arterioles from both young and middle-age females (Fig 8A) . In coronary arterioles from middle-aged and old OVX rats, estrogen-replacement increased AKT mRNA expression to levels greater than those of arterioles from age-matched intact rats (Fig 8A) .
Similar to AKT mRNA, advancing age also caused a decrease in eNOS mRNA in coronary arterioles from middle-age and old intact females compared to arterioles from young females; however, OVX did not alter eNOS mRNA in any age group (Fig 8B) .
OVE upregulated eNOS mRNA in both young and middle-age females compared to intact and OVX (Fig 8B) . Surprisingly, OVE did not alter eNOS mRNA in coronary arterioles from old rats (Fig 8B) .
p-eNOS, p-AKT, eNOS, and AKT protein levels
Basal p-AKT was undetectable in coronary arterioles from all groups. Total AKT and eNOS protein levels of coronary arterioles were not altered by age or changes in ovarian hormones (Fig 9) . Coronary arterioles from young females exhibited no changes in total eNOS protein or p-eNOS after OVX or OVE (Fig 9B) . In middle-age females, neither OVX nor OVE altered total eNOS protein levels ( Fig 9C) ; however, there was a 93% increase in p-eNOS after OVE treatment in middle-age females (Fig 9C) . Similarly, total eNOS did not change with OVX or OVE in coronary arterioles from old females (Fig 9D) , but estrogen-replacement increased p-eNOS levels by 45% in arterioles from old OVE females as compared to arterioles from old OVX rats.
DISCUSSION
Although there are numerous reports in the literature detailing the beneficial influence of estrogen replacement on the vasculature in young animals (4, 10, 14, 41), to our knowledge this is the first study to examine the effects of estrogen supplementation on the coronary vasculature in female rats of an advanced age. The foremost finding of this study is that age reduces flow-induced, NO-mediated vasodilation of coronary arterioles of female rats, and estrogen replacement improves flow-induced dilation in coronary arterioles of old female rats, indicating a favorable coronary endothelial response to estrogen-replacement in this aged population. This improvement in endothelium-dependent, NO-mediated dilation is accompanied by an increase in phosphorylation of eNOS protein after estrogen-replacement. Congruent with the finding that estrogen replacement improved flow-induced dilation in rats with low levels of circulating estradiol, ovariectomy reduced flow-induced, NO-mediated vasodilation in coronary arterioles from young females, and estrogen replacement restored NO-mediated dilation to flow in coronary arterioles from young and middle-age ovariectomized rats.
Together these findings indicate that the age-related loss of endothelium-dependent dilation to flow in coronary arterioles occurs, in part, due to declining levels of ovarian estrogen, and that estrogen supplementation can improve flow-induced dilation, even at an advanced age.
Endothelium-dependent vasodilation has been shown to correlate inversely with age in large epicardial coronary arteries (8) . Vasodilation of coronary arteries in response to noradrenaline (29) , adenosine (16) , and testosterone (9) declines with age.
Additionally, impaired endothelium-dependent vasodilation of septal arteries (~200 μm)
in middle-aged male rats has been reported (6); however, much of the current literature regarding aging effects in the coronary vasculature is confined to studies of larger resistance arteries from males. The novelty of this study is the examination of the coronary resistance vasculture at three critical stages in the reproductive lifespan of female rats: young adulthood, reproductive senescence, and senescence. The present study illustrates an age-related impairment in endothelium-dependent dilation in coronary arterioles from female rats, which is associated with a loss of NO-dependent dilation ( Fig   4) and a decrease in phosphorylation of eNOS protein (Fig 9A) . These findings extend previous studies showing that flow-induced dilation in females decreases with advancing age in brachial arteries (5, 33) and mesenteric arteries (1) by demonstrating that agerelated endothelial impairment also occurs in resistance arterioles where endothelial responsiveness is critical to flow distribution.
In the present study, young females were the only age group in which OVX decreased flow-induced dilation of coronary arterioles. L-NAME treatment reduced flow-induced dilation of arterioles from young females before OVX, but L-NAME had no effect on the response to flow after OVX. In contrast, L-NAME did not alter flowinduced dilation of arterioles from either intact or OVX middle-age and old females, suggesting that a loss of ovarian hormones, whether induced by ovariectomy or aging, leads to a decline in flow-induced NOS signaling. Estrogen-replacement after OVX enhanced flow-induced, NO-mediated dilation of coronary arterioles from all age groups (Fig 3) . Restoration of NO-dependent dilation by estrogen replacement has been observed previously in cerebral arteries (34) and in the coronary microcirculation of guinea pigs (50) at a young age. Additionally, several human studies have shown that HRT in postmenopausal women improves flow-induced dilation in peripheral conduit arteries (7, 24, 38) . The current data indicate that estrogen supplementation also improves flow-induced vasodilation in the coronary resistance vasculature at all ages, primarily through enhancement of NOS-mediated signaling.
Vasodilation to flow was unaltered by L-NAME treatment in coronary arterioles from OVX rats. In addition, substantial dilation to flow remained in arterioles from all arterioles at any age; however, eNOS mRNA is upregulated by estrogen replacement in coronary arterioles from young and middle-age females (Fig 8B) . Surprisingly, but in keeping with findings reported in cerebral microvessels (20), mesenteric arteries (30), and left ventricular tissue (3), neither age or estrogen status altered total eNOS protein in coronary arterioles. Although total eNOS was not affected by estrogen status, phosphorylation of eNOS protein (serine 1177) was increased in arterioles from middleage and old females after estrogen-replacement. In coronary arterioles from male rats, we have previously reported that advancing age impairs flow-induced vasodilation through reductions in Flk-1 activation and PI3-kinase/Akt signaling (23) . Similar to our findings in coronary arterioles from old male rats, our current results indicate that basal NO remained constant (Table 2 ) despite changes in NO-mediated dilation that occurred with advancing age and manipulation of circulating estrogen. Thus, our data suggest that changes in NO-mediated signaling that occur with age and alterations of estrogen status in female rats are more likely related to modifications in regulation of eNOS activity rather than adaptations in eNOS expression. Future studies in which phosporylation of eNOS at other regulatory sites and feedback of NO and reactive oxygen species on eNOS transcription and translation will be needed to provide a more comprehensive understanding of the effects of age and estrogen status on regulation of eNOS expression and function in the coronary endothelium of female rats.
Although molecular evidence shows that AKT is responsive to the presence of estrogen (10, 18, 44) , previous studies focused on the acute effects of estrogen exposure rather than the chronic estrogen supplementation. In endothelial cells, acute administration of estrogen causes phosphorylation of AKT within one minute (10);
however, we found that phosphorylated AKT was undetectable in coronary arteriolar samples under basal conditions. Bhuiyan et al. (3) found no changes in phosphorylated AKT or total AKT protein after OVX in left ventricular tissue from female Wistar rats.
Although it would seem reasonable that circulating estrogen affects both AKT mRNA and AKT protein similarly, our data indicate that chronic changes in estrogen altered AKT mRNA expression, but not AKT protein levels. The results suggest that estrogen exerts differential effects on transcription, translation, and activation of AKT. Our results also suggest that modifications of AKT mRNA expression induced by alterations of estrogen status are unlikely to be a critical factor in the changes in NO signaling that occur with advancing age or estrogen supplementation.
PERSPECTIVES AND SIGNIFICANCE
The major finding from this study is that estrogen-replacement following groups. OVX decreased uterine weight in all groups compared to age-matched intact females, whereas uterine weight was increased with estrogen replacement after OVX in all groups. Plasma estradiol was greater in young intact compared to middle-aged and old intact females. OVX decreased estradiol in young rats only. Estrogen-replacement after OVX increased estradiol in old females compared to old intact, whereas OVE in young rats brought estradiol levels back to those seen in young intact. Values are means ± SE. *Indicates significance compared to estrogen status-matched young group, †Indicates significance compared to age-matched OVX group (P ≤ 0.05). 
OVX (O), or OVE (E).
Values are means ± SE. * Indicates significant age-related difference vs. young intact, †Indicates significant OVX effect vs. age-matched intact, ‡Indicates significant OVE effect vs. age-matched intact, §Indicates significant OVE effect vs. age-matched OVX (P ≤ 0.05). Figure 9 . Densitometric analysis of p-eNOS with respective representative blots for total eNOS, AKT, and β-actin below. Phospho-AKT was undetectable in all groups. Levels of total AKT and total eNOS were similar in all age and estrogen treatment groups.
There was an age-dependent decrease in p-eNOS protein (A) (YI: n=8, MI: n=4, OI: n=7 
